Stocks / NASDAQ / ProKidney Corp.

ProKidney Corp.

Our Opinion

ProKidney Corp. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company mentioned on its website that they use animals for drug testing.

“Preclinical studies in animal models have suggested that selected renal cells can integrate into the damaged kidney tissue and improve both renal function and histopathology, as illustrated in steps 5-7 below, as well as the two diagrams that follow.” Read the following article

Company Description

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases. The company’s lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture that is in Phase I for REACT in patients with Congenital Anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Company Website: